Page last updated: 2024-08-23

azoxymethane and Cirrhosis

azoxymethane has been researched along with Cirrhosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Donthi, D; Hong, H; Lertpiriyapong, K; Marie, MA; Sanderlin, EJ; Satturwar, S; Yang, LV1
Ahmad, D; Cheng, K; Jadeja, RN; Khurana, S; Rachakonda, V; Raufman, JP; Shah, N; Twaddell, WS; Urrunaga, NH1

Other Studies

2 other study(ies) available for azoxymethane and Cirrhosis

ArticleYear
GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models.
    Biochimica et biophysica acta. Molecular basis of disease, 2022, 01-01, Volume: 1868, Issue:1

    Topics: Animals; Azoxymethane; Colitis; Colitis-Associated Neoplasms; Colon; Dextran Sulfate; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Humans; Inflammation; Inflammatory Bowel Diseases; Leukocytes; Mice; Mice, Knockout; Receptors, G-Protein-Coupled; Severity of Illness Index

2022
M1 Muscarinic Receptor Deficiency Attenuates Azoxymethane-Induced Chronic Liver Injury in Mice.
    Scientific reports, 2015, Sep-16, Volume: 5

    Topics: Acute Disease; Animals; Apoptosis; Azoxymethane; Bile Ducts; Cell Survival; Disease Models, Animal; Fibrosis; Hepatic Stellate Cells; Hepatocytes; Hyperplasia; Liver Diseases; Matrix Metalloproteinases; Mice; Mice, Knockout; Oxidative Stress; Receptor, Muscarinic M1; Tissue Inhibitor of Metalloproteinases

2015